Clinical trials: sponsored by Zagazig University

COVID

Prophylactic Ivermectin in COVID-19 Contacts

• Completed
• Age: 16 to 70 years
• Phase 2/3
• Pill or oral medicine
• Results posted

asymptomatic family close contact of confirmed COVID -19 patient will receive prophylactic ivermectin and will be followed up for 14 days for any symptoms \& diagnosis of COVID -19

Trial name

NCT04422561

Testing

Ivermectin Tablets

Where

Egypt

Volunteers

340 people, healthy volunteers welcome

Sponsor

Zagazig University